Latest Insider Transactions at Glaukos Corp (GKOS)
This section provides a real-time view of insider transactions for Glaukos Corp (GKOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GLAUKOS Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GLAUKOS Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2021
|
Joseph E Gilliam PRESIDENT & COO |
BUY
Grant, award, or other acquisition
|
Direct |
15,499
+21.0%
|
-
|
|
Mar 18
2021
|
Thomas William Burns CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
38,247
+5.1%
|
-
|
|
Mar 15
2021
|
Joseph E Gilliam PRESIDENT & COO |
SELL
Open market or private sale
|
Direct |
5,000
-10.46%
|
$435,000
$87.88 P/Share
|
|
Mar 15
2021
|
Joseph E Gilliam PRESIDENT & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.47%
|
$195,000
$39.1 P/Share
|
|
Mar 03
2021
|
Gilbert H Kliman |
BUY
Other acquisition or disposition
|
Direct |
680
+9.61%
|
-
|
|
Mar 03
2021
|
Gilbert H Kliman |
SELL
Other acquisition or disposition
|
Indirect |
303,000
-73.66%
|
-
|
|
Mar 03
2021
|
Gilbert H Kliman |
BUY
Other acquisition or disposition
|
Indirect |
3,000
+50.0%
|
-
|
|
Mar 01
2021
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+30.64%
|
-
|
|
Mar 01
2021
|
Leana Wen |
BUY
Grant, award, or other acquisition
|
Direct |
3,528
+30.64%
|
-
|
|
Feb 09
2021
|
Joseph E Gilliam PRESIDENT & COO |
SELL
Open market or private sale
|
Direct |
13,750
-12.67%
|
$1,320,000
$96.75 P/Share
|
|
Feb 09
2021
|
Joseph E Gilliam PRESIDENT & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+11.24%
|
$495,000
$36.3 P/Share
|
|
Feb 01
2021
|
Chris M. Calcaterra Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
60,417
-7.49%
|
$5,316,696
$88.16 P/Share
|
|
Feb 01
2021
|
Chris M. Calcaterra Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,417
+21.23%
|
$966,672
$16.49 P/Share
|
|
Jan 04
2021
|
David F Hoffmeister |
BUY
Grant, award, or other acquisition
|
Direct |
980
+5.57%
|
-
|
|
Jan 04
2021
|
Mark J Foley |
BUY
Grant, award, or other acquisition
|
Direct |
1,184
+8.74%
|
-
|
|
Jan 04
2021
|
Gilbert H Kliman |
BUY
Grant, award, or other acquisition
|
Direct |
980
+14.64%
|
-
|
|
Jan 04
2021
|
Marc Stapley |
BUY
Grant, award, or other acquisition
|
Direct |
1,184
+6.28%
|
-
|
|
Jan 04
2021
|
Aimee S Weisner |
BUY
Grant, award, or other acquisition
|
Direct |
980
+6.33%
|
-
|
|
Dec 17
2020
|
Joseph E Gilliam PRESIDENT & COO |
SELL
Other acquisition or disposition
|
Direct |
2,069
-4.61%
|
-
|
|
Dec 17
2020
|
Joseph E Gilliam PRESIDENT & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,164
+2.53%
|
$83,808
$72.99 P/Share
|
|
Dec 17
2020
|
Chris M. Calcaterra Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,233
+0.75%
|
$88,776
$72.99 P/Share
|
|
Dec 17
2020
|
Thomas William Burns CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,389
+0.75%
|
$172,008
$72.99 P/Share
|
|
Dec 16
2020
|
Chris M. Calcaterra Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,128
+2.48%
|
$293,088
$71.94 P/Share
|
|
Dec 16
2020
|
Thomas William Burns CHAIRMAN & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,789
+3.01%
|
$695,019
$71.94 P/Share
|
|
Dec 16
2020
|
Joseph E Gilliam PRESIDENT & COO |
BUY
Grant, award, or other acquisition
|
Direct |
3,182
+6.79%
|
$225,922
$71.94 P/Share
|
|
Dec 01
2020
|
William J Phd Link Director |
SELL
Open market or private sale
|
Direct |
50,000
-39.62%
|
$3,400,000
$68.34 P/Share
|
|
Dec 01
2020
|
William J Phd Link Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.67%
|
$1,050,000
$21.32 P/Share
|
|
Mar 06
2018
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
161,321
-62.77%
|
$4,839,630
$30.95 P/Share
|
|
Mar 05
2018
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
210,596
-34.14%
|
$6,739,072
$32.56 P/Share
|
|
Mar 02
2018
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
464,583
-33.31%
|
$14,866,656
$32.36 P/Share
|
|
Sep 05
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
425,200
-12.68%
|
$16,582,800
$39.45 P/Share
|
|
Sep 01
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
110,078
-8.02%
|
$4,072,886
$37.72 P/Share
|
|
Aug 31
2017
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
44,922
-3.17%
|
$1,662,114
$37.82 P/Share
|